Table 3: Ethnic analyses.
Chinese N = 111 (%) |
Malay N = 58 (%) |
Indian N = 16 (%) |
Others N = 25 (%) |
|
Age |
|
|
|
|
Median (Range) |
54.1 (10-92) |
45.2 (8-78) |
54.8 (33-83) |
50 (8-73) |
Gender (p = 0.839) |
|
|
|
|
Female |
48 (43.2) |
28 (48.3) |
6 (37.5) |
12 (48.0) |
Male |
63 (56.8) |
30 (51.7) |
10 (62.5) |
13 (52.0) |
Site (p = 0.656) |
|
|
|
|
Nodal |
54 (48.6) |
25 (43.1) |
8 (50.0) |
9 (36.0) |
Extranodal |
57 (51.4) |
33 (56.9) |
8 (50.0) |
16 (64.0) |
Lymphoma Subtype |
|
|
|
|
DLBCL, NOS |
51 (45.9) |
34 (58.6) |
6 (37.5) |
16 (64.0) |
Plasmablastic |
3 (2.7) |
0 (0.0) |
1 (6.3) |
0 (0.0) |
FL |
13 (11.7) |
5 (8.6) |
2 (12.5) |
1 (4.0) |
MZL |
10 (9.0) |
2 (3.4) |
0 (0.0) |
4 (16.0) |
MCL |
4 (3.6) |
0 (0.0) |
1 (6.3) |
1 (4.0) |
BL |
2 (1.8) |
3 (5.2) |
1 (6.3) |
0 (0.0) |
SLL |
1 (0.9) |
1 (1.7) |
1 (6.3) |
0 (0.0) |
Lymphoblastic Lymphoma |
1 (0.9) |
2 (3.4) |
0 (0.0) |
0 (0.0) |
B-cell NHL (No category) |
6 (5.4) |
2 (3.4) |
0 (0.0) |
1 (4.0) |
T-cell NHL |
9 (8.1) |
0 (0.0) |
1 (6.3) |
0 (0.0) |
HL |
11 (9.9) |
9 (15.5) |
3 (18.8) |
2 (8.0) |